ASX Announcements

Quarterly report and cash flow statement for Q3 2020
Neuren requests Orphan designations for NNZ-2591 in Europe
Neuren initiates manufacture of NNZ-2591 for Phase 2 trials
Half-year Shareholder Update
Half Yearly Report and Accounts
Corporate presentation, 18 August 2020
Change of Director's Interest Notice
Appendix 2A
Change of Director's Interest Notice
Completion of Share Purchase Plan